Overview

Oligonucleotide API Market is poised to value USD 4406 million by 2028 end at a CAGR of 10.2% during the forecast period 2022 to 2028. 

Oligonucleotides are a novel form of pharmaceutical molecule that can be utilised to treat a variety of diseases. They're little strands of altered DNA, around 20 nucleotides long. The most common process for generating oligonucleotides is to isolate the active pharmaceutical ingredient (API) by lyophilization to make a solid product, which is then dissolved to produce an aqueous formulation.

Oligonucleotide active pharmaceutical ingredients (APIs) have previously been utilised in solid solutions (powdered form) and, more recently, in solution form. The oligonucleotide active pharmaceutical ingredient (API) sector is being driven by the widespread usage of oligonucleotide active pharmaceutical ingredients in the treatment of various illnesses. Product development has cleared the way for novel therapeutic procedures in a variety of fields, including ophthalmology, neuromuscular diseases, and vaccine adjuvants.

Some of the most significant oligonucleotide classes include micro-RNA, small/short interfering RNA, antisense oligonucleotides, immunostimulatory oligonucleotides, aptamers, and splice-switching oligonucleotides. Some of the characteristics that have boosted the trend of oligonucleotide APIs in solution include solution stability, viscosity, concentration, end-to-end production, and packaging.

Because of major breakthroughs made in industry associations regarding CMC (chemistry, manufacturing, and control) methodologies, the market for oligonucleotide APIs is looking brighter. The market for innovative medication classes for chronic obstructive pulmonary disease and asthma is expanding, creating new opportunities.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Oligonucleotide API Market  trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Oligonucleotide API Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Oligonucleotide API Market:
• Agilent Technologies, Inc.
• Bachem Holding AG
• CordenPharma International
• Integrated DNA Technologies, Inc. (Danaher Corporation)
• Eurofins Scientific
• GE Healthcare
• Merck KGaA
• Thermo Fisher Scientific
• RiBoBio Co.
• LGC Biosearch Technologies
• ST Pharm
• Kaneka Eurogentec S.A.
• Ajinomoto Co., Inc.
• Bio-synthesis Inc.
• STA Pharmaceutical Co., Ltd.
• BioSpring GmbH
(Note: The list of the major players will be updated with the latest market scenario and trends)

Oligonucleotide API Market Segmentation:
By API Type
• Antisense Oligonucleotides API
• Short Interfering RNA (siRNA) API
• Phosphorodiamidate Morpholino Oligonucleotides (PMO) API
• MiRNA API
• Aptamers API
• CpG Oligonucleotides API
• Others (ON Conjugates (NP), ShRNA, etc.)
By Marketing Status
• Marketed
• Clinical Trials (Clinical Phases)
By End User
• Contract Manufacturing Organizations (CMOs)
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Development & Manufacturing Organizations (CDMOs)
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Oligonucleotide API Market By API Type, By Marketing Status, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics